RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재후보

      Activation of the Renal PI3K/Akt/mTOR Signaling Pathway in a DOCA-Salt Model of Hypertension

      한글로보기

      https://www.riss.kr/link?id=A104271581

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      The present study investigated the changes that occurred in the mammalian target of rapamycin (mTOR) signaling pathway in the kidney as a result of deoxycorticosterone acetate (DOCA)-salt hypertension. Rats were implanted with DOCA strips (200mg/kg) 1 week after unilateral nephrectomy and were then supplied with 0.9% saline to drink. Four weeks after DOCA implantation, systolic blood pressure (SBP) was measured by use of the tail-cuff method. The expression levels of phosphorylated phosphatidylinositol-3-kinase (PI3K), Akt, and mTOR, as well as the protein expression levels of ED-1 and cyclooxygenase-2 (COX-2), transforming growth factor-β1 (TGF-β1), α-smooth muscle actin (SMA), caspase-3, Bax, and Bcl-2, were then examined in the kidney by semiquantitative immunoblotting. DOCA-salt hypertensive rats were found to have significantly increased SBP as well as an increased kidney weight-to-body weight ratio. Moreover, the phosphorylation of PI3K, Akt, and mTOR was increased in the kidney of DOCA-salt hypertensive rats compared with the control, as was the protein expression of ED-1, COX-2, TGF-β1, and α-SMA. The expression levels of caspase-3 and Bax were increased significantly, whereas Bcl-2 expression was decreased. In conclusion,the phosphorylation of PI3K/Akt/mTOR was increased in the kidney of DOCA-salt hypertensive rats.
      번역하기

      The present study investigated the changes that occurred in the mammalian target of rapamycin (mTOR) signaling pathway in the kidney as a result of deoxycorticosterone acetate (DOCA)-salt hypertension. Rats were implanted with DOCA strips (200mg/kg) 1...

      The present study investigated the changes that occurred in the mammalian target of rapamycin (mTOR) signaling pathway in the kidney as a result of deoxycorticosterone acetate (DOCA)-salt hypertension. Rats were implanted with DOCA strips (200mg/kg) 1 week after unilateral nephrectomy and were then supplied with 0.9% saline to drink. Four weeks after DOCA implantation, systolic blood pressure (SBP) was measured by use of the tail-cuff method. The expression levels of phosphorylated phosphatidylinositol-3-kinase (PI3K), Akt, and mTOR, as well as the protein expression levels of ED-1 and cyclooxygenase-2 (COX-2), transforming growth factor-β1 (TGF-β1), α-smooth muscle actin (SMA), caspase-3, Bax, and Bcl-2, were then examined in the kidney by semiquantitative immunoblotting. DOCA-salt hypertensive rats were found to have significantly increased SBP as well as an increased kidney weight-to-body weight ratio. Moreover, the phosphorylation of PI3K, Akt, and mTOR was increased in the kidney of DOCA-salt hypertensive rats compared with the control, as was the protein expression of ED-1, COX-2, TGF-β1, and α-SMA. The expression levels of caspase-3 and Bax were increased significantly, whereas Bcl-2 expression was decreased. In conclusion,the phosphorylation of PI3K/Akt/mTOR was increased in the kidney of DOCA-salt hypertensive rats.

      더보기

      참고문헌 (Reference)

      1 Hay N, "Upstream and downstream of mTOR" 18 : 1926-1945, 2004

      2 Lieberthal W, "The role of the mammalian target of rapamycin(mTOR) in renal disease" 20 : 2493-2502, 2009

      3 Bae EH, "Rosiglitazone prevents the progression of renal injury in DOCA-salt hypertensive rats" 33 : 255-262, 2010

      4 Chen JK, "Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy" 16 : 1384-1391, 2005

      5 Bae EH, "Renoprotective effect of rosuvastatin in DOCA-salt hypertensive rats" 25 : 1051-1059, 2010

      6 Sataranatarajan K, "Regulation of elongation phase of mRNA translation in diabetic nephropathy: amelioration by rapamycin" 171 : 1733-1742, 2007

      7 Wu MJ, "Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis" 69 : 2029-2036, 2006

      8 Liu Y., "Rapamycin and chronic kidney disease: beyond the inhibition of inflammation" 69 : 1925-1927, 2006

      9 Park JW, "Paricalcitol attenuates cyclosporine-induced kidney injury in rats" 77 : 1076-1085, 2010

      10 Iwazu Y, "Matrix metalloproteinase 2 induces epithelial-mesenchymal transition in proximal tubules from the luminal side and progresses fibrosis in mineralocorticoid/salt-induced hypertensive rats" 29 : 2440-2453, 2011

      1 Hay N, "Upstream and downstream of mTOR" 18 : 1926-1945, 2004

      2 Lieberthal W, "The role of the mammalian target of rapamycin(mTOR) in renal disease" 20 : 2493-2502, 2009

      3 Bae EH, "Rosiglitazone prevents the progression of renal injury in DOCA-salt hypertensive rats" 33 : 255-262, 2010

      4 Chen JK, "Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy" 16 : 1384-1391, 2005

      5 Bae EH, "Renoprotective effect of rosuvastatin in DOCA-salt hypertensive rats" 25 : 1051-1059, 2010

      6 Sataranatarajan K, "Regulation of elongation phase of mRNA translation in diabetic nephropathy: amelioration by rapamycin" 171 : 1733-1742, 2007

      7 Wu MJ, "Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis" 69 : 2029-2036, 2006

      8 Liu Y., "Rapamycin and chronic kidney disease: beyond the inhibition of inflammation" 69 : 1925-1927, 2006

      9 Park JW, "Paricalcitol attenuates cyclosporine-induced kidney injury in rats" 77 : 1076-1085, 2010

      10 Iwazu Y, "Matrix metalloproteinase 2 induces epithelial-mesenchymal transition in proximal tubules from the luminal side and progresses fibrosis in mineralocorticoid/salt-induced hypertensive rats" 29 : 2440-2453, 2011

      11 Lloberas N, "Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats" 17 : 1395-1404, 2006

      12 Diekmann F, "Mammalian target of rapamycin inhibition halts the progression of proteinuria in a rat model of reduced renal mass" 18 : 2653-2660, 2007

      13 Gavras H, "Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes" 36 : 300-309, 1975

      14 Iglarz M, "Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction wtih the renin-angiotension system" 17 : 597-603, 2004

      15 Hostetter TH, "Hyperfiltration and glomerulosclerosis" 23 : 194-199, 2003

      16 Mariappan MM, "High glucose, high insulin, and their combination rapidly induce laminin-beta1 synthesis by regulation of mRNA translation in renal epithelial cells" 56 : 476-485, 2007

      17 Katso R, "Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer" 17 : 615-675, 2001

      18 Lijnen PJ, "Association between transforming growth factor-beta and hypertension" 16 : 604-611, 2003

      19 Miyajima A, "Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction" 58 : 2301-2313, 2000

      20 Bae EH, "Altered regulation of renal sodium transporters and natriuretic peptide system in DOCA-salt hypertensive rats" 157 : 76-83, 2009

      21 Huang S, "Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation" 296 : 1323-1333, 2009

      22 Sun Y, "Aldosterone-induced inflammation in the rat heart : role of oxidative stress" 161 : 1773-1781, 2002

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2027 평가예정 재인증평가 신청대상 (재인증)
      2021-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2018-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2015-01-01 평가 등재학술지 선정 (계속평가) KCI등재
      2013-01-01 평가 등재후보학술지 유지 (기타) KCI등재후보
      2012-01-01 평가 등재후보 1차 FAIL (등재후보1차) KCI등재후보
      2010-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.16 0.16 0.11
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.1 0.08 0.34 0.06
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼